
STM · NYSE
Consensus is Buy across all 12 analysts, with a stated mean target of $72.5; the supplied consensus does not report low or high targets. Published reference points cluster around $71.65-$73.54, but a separate three-analyst source gives a $61.50 median, indicating a meaningful spread beneath the headline mean. Mizuho is the least bullish named analyst in the evidence, with a $48 target after its April 17 action; no source identifies the most bullish individual analyst. Revisions appear directionally positive over the longer period, as ChartMill reports a 62.52% increase in its average target over three months, but no target or rating revision is documented during the past week. The substantive disagreement is whether STM’s weak FY2025 results are temporary or justify lower targets.